The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antipsychotic Medications Market Research Report 2025
Synopsis
Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
The global Antipsychotic Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medications.
Report Scope
The Antipsychotic Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipsychotic Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Segment by Type
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Tetracyclic Antidepressants (TeCAs)
Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Segment by Application
Hospital Pharmacies
Drug Stores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipsychotic Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antipsychotic Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
The global Antipsychotic Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medications.
Report Scope
The Antipsychotic Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipsychotic Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Segment by Type
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Tetracyclic Antidepressants (TeCAs)
Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Segment by Application
Hospital Pharmacies
Drug Stores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipsychotic Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antipsychotic Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antipsychotic Medications Market Overview
1.1 Product Overview and Scope of Antipsychotic Medications
1.2 Antipsychotic Medications Segment by Type
1.2.1 Global Antipsychotic Medications Market Value Comparison by Type (2024-2030)
1.2.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
1.2.3 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
1.2.4 Tricyclic Antidepressants (TCAs)
1.2.5 Monoamine Oxidase Inhibitors (MAOIs)
1.2.6 Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
1.2.7 Tetracyclic Antidepressants (TeCAs)
1.2.8 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
1.3 Antipsychotic Medications Segment by Application
1.3.1 Global Antipsychotic Medications Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Others
1.4 Global Antipsychotic Medications Market Size Estimates and Forecasts
1.4.1 Global Antipsychotic Medications Revenue 2019-2030
1.4.2 Global Antipsychotic Medications Sales 2019-2030
1.4.3 Global Antipsychotic Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antipsychotic Medications Market Competition by Manufacturers
2.1 Global Antipsychotic Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antipsychotic Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antipsychotic Medications Average Price by Manufacturers (2019-2024)
2.4 Global Antipsychotic Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antipsychotic Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antipsychotic Medications, Product Type & Application
2.7 Antipsychotic Medications Market Competitive Situation and Trends
2.7.1 Antipsychotic Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antipsychotic Medications Players Market Share by Revenue
2.7.3 Global Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antipsychotic Medications Retrospective Market Scenario by Region
3.1 Global Antipsychotic Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antipsychotic Medications Global Antipsychotic Medications Sales by Region: 2019-2030
3.2.1 Global Antipsychotic Medications Sales by Region: 2019-2024
3.2.2 Global Antipsychotic Medications Sales by Region: 2025-2030
3.3 Global Antipsychotic Medications Global Antipsychotic Medications Revenue by Region: 2019-2030
3.3.1 Global Antipsychotic Medications Revenue by Region: 2019-2024
3.3.2 Global Antipsychotic Medications Revenue by Region: 2025-2030
3.4 North America Antipsychotic Medications Market Facts & Figures by Country
3.4.1 North America Antipsychotic Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antipsychotic Medications Sales by Country (2019-2030)
3.4.3 North America Antipsychotic Medications Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antipsychotic Medications Market Facts & Figures by Country
3.5.1 Europe Antipsychotic Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antipsychotic Medications Sales by Country (2019-2030)
3.5.3 Europe Antipsychotic Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipsychotic Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Antipsychotic Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antipsychotic Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Antipsychotic Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antipsychotic Medications Market Facts & Figures by Country
3.7.1 Latin America Antipsychotic Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antipsychotic Medications Sales by Country (2019-2030)
3.7.3 Latin America Antipsychotic Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipsychotic Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipsychotic Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antipsychotic Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antipsychotic Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antipsychotic Medications Sales by Type (2019-2030)
4.1.1 Global Antipsychotic Medications Sales by Type (2019-2024)
4.1.2 Global Antipsychotic Medications Sales by Type (2025-2030)
4.1.3 Global Antipsychotic Medications Sales Market Share by Type (2019-2030)
4.2 Global Antipsychotic Medications Revenue by Type (2019-2030)
4.2.1 Global Antipsychotic Medications Revenue by Type (2019-2024)
4.2.2 Global Antipsychotic Medications Revenue by Type (2025-2030)
4.2.3 Global Antipsychotic Medications Revenue Market Share by Type (2019-2030)
4.3 Global Antipsychotic Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antipsychotic Medications Sales by Application (2019-2030)
5.1.1 Global Antipsychotic Medications Sales by Application (2019-2024)
5.1.2 Global Antipsychotic Medications Sales by Application (2025-2030)
5.1.3 Global Antipsychotic Medications Sales Market Share by Application (2019-2030)
5.2 Global Antipsychotic Medications Revenue by Application (2019-2030)
5.2.1 Global Antipsychotic Medications Revenue by Application (2019-2024)
5.2.2 Global Antipsychotic Medications Revenue by Application (2025-2030)
5.2.3 Global Antipsychotic Medications Revenue Market Share by Application (2019-2030)
5.3 Global Antipsychotic Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson and Johnson Antipsychotic Medications Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Antipsychotic Medications Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bristol-Myers Squibb Antipsychotic Medications Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Antipsychotic Medications Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Antipsychotic Medications Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Antipsychotic Medications Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Antipsychotic Medications Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Antipsychotic Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Antipsychotic Medications Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipsychotic Medications Industry Chain Analysis
7.2 Antipsychotic Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipsychotic Medications Production Mode & Process
7.4 Antipsychotic Medications Sales and Marketing
7.4.1 Antipsychotic Medications Sales Channels
7.4.2 Antipsychotic Medications Distributors
7.5 Antipsychotic Medications Customers
8 Antipsychotic Medications Market Dynamics
8.1 Antipsychotic Medications Industry Trends
8.2 Antipsychotic Medications Market Drivers
8.3 Antipsychotic Medications Market Challenges
8.4 Antipsychotic Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antipsychotic Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antipsychotic Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Antipsychotic Medications Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antipsychotic Medications Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Antipsychotic Medications Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antipsychotic Medications Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antipsychotic Medications Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antipsychotic Medications Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antipsychotic Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antipsychotic Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antipsychotic Medications, Product Type & Application
Table 12. Global Key Manufacturers of Antipsychotic Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antipsychotic Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medications as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antipsychotic Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antipsychotic Medications Sales by Region (2019-2024) & (K Units)
Table 18. Global Antipsychotic Medications Sales Market Share by Region (2019-2024)
Table 19. Global Antipsychotic Medications Sales by Region (2025-2030) & (K Units)
Table 20. Global Antipsychotic Medications Sales Market Share by Region (2025-2030)
Table 21. Global Antipsychotic Medications Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antipsychotic Medications Revenue Market Share by Region (2019-2024)
Table 23. Global Antipsychotic Medications Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antipsychotic Medications Revenue Market Share by Region (2025-2030)
Table 25. North America Antipsychotic Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antipsychotic Medications Sales by Country (2019-2024) & (K Units)
Table 27. North America Antipsychotic Medications Sales by Country (2025-2030) & (K Units)
Table 28. North America Antipsychotic Medications Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antipsychotic Medications Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antipsychotic Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antipsychotic Medications Sales by Country (2019-2024) & (K Units)
Table 32. Europe Antipsychotic Medications Sales by Country (2025-2030) & (K Units)
Table 33. Europe Antipsychotic Medications Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antipsychotic Medications Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antipsychotic Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antipsychotic Medications Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Antipsychotic Medications Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Antipsychotic Medications Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antipsychotic Medications Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antipsychotic Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antipsychotic Medications Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Antipsychotic Medications Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Antipsychotic Medications Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antipsychotic Medications Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antipsychotic Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Antipsychotic Medications Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Antipsychotic Medications Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Antipsychotic Medications Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antipsychotic Medications Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antipsychotic Medications Sales (K Units) by Type (2019-2024)
Table 51. Global Antipsychotic Medications Sales (K Units) by Type (2025-2030)
Table 52. Global Antipsychotic Medications Sales Market Share by Type (2019-2024)
Table 53. Global Antipsychotic Medications Sales Market Share by Type (2025-2030)
Table 54. Global Antipsychotic Medications Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antipsychotic Medications Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antipsychotic Medications Revenue Market Share by Type (2019-2024)
Table 57. Global Antipsychotic Medications Revenue Market Share by Type (2025-2030)
Table 58. Global Antipsychotic Medications Price (USD/Unit) by Type (2019-2024)
Table 59. Global Antipsychotic Medications Price (USD/Unit) by Type (2025-2030)
Table 60. Global Antipsychotic Medications Sales (K Units) by Application (2019-2024)
Table 61. Global Antipsychotic Medications Sales (K Units) by Application (2025-2030)
Table 62. Global Antipsychotic Medications Sales Market Share by Application (2019-2024)
Table 63. Global Antipsychotic Medications Sales Market Share by Application (2025-2030)
Table 64. Global Antipsychotic Medications Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antipsychotic Medications Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antipsychotic Medications Revenue Market Share by Application (2019-2024)
Table 67. Global Antipsychotic Medications Revenue Market Share by Application (2025-2030)
Table 68. Global Antipsychotic Medications Price (USD/Unit) by Application (2019-2024)
Table 69. Global Antipsychotic Medications Price (USD/Unit) by Application (2025-2030)
Table 70. Johnson and Johnson Corporation Information
Table 71. Johnson and Johnson Description and Business Overview
Table 72. Johnson and Johnson Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Johnson and Johnson Antipsychotic Medications Product
Table 74. Johnson and Johnson Recent Developments/Updates
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly Antipsychotic Medications Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Bristol-Myers Squibb Antipsychotic Medications Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Antipsychotic Medications Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Antipsychotic Medications Product
Table 94. Novartis Recent Developments/Updates
Table 95. Allergan Corporation Information
Table 96. Allergan Description and Business Overview
Table 97. Allergan Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Allergan Antipsychotic Medications Product
Table 99. Allergan Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Pfizer Antipsychotic Medications Product
Table 104. Pfizer Recent Developments/Updates
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. GlaxoSmithKline Antipsychotic Medications Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Antipsychotic Medications Distributors List
Table 113. Antipsychotic Medications Customers List
Table 114. Antipsychotic Medications Market Trends
Table 115. Antipsychotic Medications Market Drivers
Table 116. Antipsychotic Medications Market Challenges
Table 117. Antipsychotic Medications Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antipsychotic Medications
Figure 2. Global Antipsychotic Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antipsychotic Medications Market Share by Type in 2023 & 2030
Figure 4. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Picture
Figure 5. Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Product Picture
Figure 6. Tricyclic Antidepressants (TCAs) Product Picture
Figure 7. Monoamine Oxidase Inhibitors (MAOIs) Product Picture
Figure 8. Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Product Picture
Figure 9. Tetracyclic Antidepressants (TeCAs) Product Picture
Figure 10. Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Product Picture
Figure 11. Global Antipsychotic Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Antipsychotic Medications Market Share by Application in 2023 & 2030
Figure 13. Hospital Pharmacies
Figure 14. Drug Stores
Figure 15. Others
Figure 16. Global Antipsychotic Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Antipsychotic Medications Market Size (2019-2030) & (US$ Million)
Figure 18. Global Antipsychotic Medications Sales (2019-2030) & (K Units)
Figure 19. Global Antipsychotic Medications Average Price (USD/Unit) & (2019-2030)
Figure 20. Antipsychotic Medications Report Years Considered
Figure 21. Antipsychotic Medications Sales Share by Manufacturers in 2023
Figure 22. Global Antipsychotic Medications Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Antipsychotic Medications Players: Market Share by Revenue in 2023
Figure 24. Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Antipsychotic Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Antipsychotic Medications Sales Market Share by Country (2019-2030)
Figure 27. North America Antipsychotic Medications Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Antipsychotic Medications Sales Market Share by Country (2019-2030)
Figure 31. Europe Antipsychotic Medications Revenue Market Share by Country (2019-2030)
Figure 32. Germany Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Antipsychotic Medications Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Antipsychotic Medications Revenue Market Share by Region (2019-2030)
Figure 39. China Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Antipsychotic Medications Sales Market Share by Country (2019-2030)
Figure 50. Latin America Antipsychotic Medications Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Antipsychotic Medications Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Antipsychotic Medications Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Antipsychotic Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Antipsychotic Medications by Type (2019-2030)
Figure 60. Global Revenue Market Share of Antipsychotic Medications by Type (2019-2030)
Figure 61. Global Antipsychotic Medications Price (USD/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Antipsychotic Medications by Application (2019-2030)
Figure 63. Global Revenue Market Share of Antipsychotic Medications by Application (2019-2030)
Figure 64. Global Antipsychotic Medications Price (USD/Unit) by Application (2019-2030)
Figure 65. Antipsychotic Medications Value Chain
Figure 66. Antipsychotic Medications Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
